193 related articles for article (PubMed ID: 20440842)
1. Chemical synthesis and characterization of wild-type and biotinylated N-terminal domain 1-64 of beta2-glycoprotein I.
Pozzi N; Banzato A; Bettin S; Bison E; Pengo V; De Filippis V
Protein Sci; 2010 May; 19(5):1065-78. PubMed ID: 20440842
[TBL] [Abstract][Full Text] [Related]
2. Anti-beta 2-glycoprotein I autoantibodies from patients with the "antiphospholipid" syndrome bind to beta 2-glycoprotein I with low affinity: dimerization of beta 2-glycoprotein I induces a significant increase in anti-beta 2-glycoprotein I antibody affinity.
Sheng Y; Kandiah DA; Krilis SA
J Immunol; 1998 Aug; 161(4):2038-43. PubMed ID: 9712077
[TBL] [Abstract][Full Text] [Related]
3. The J-elongated conformation of β
Ruben E; Planer W; Chinnaraj M; Chen Z; Zuo X; Pengo V; De Filippis V; Alluri RK; McCrae KR; Macor P; Tedesco F; Pozzi N
J Biol Chem; 2020 Jul; 295(31):10794-10806. PubMed ID: 32518155
[TBL] [Abstract][Full Text] [Related]
4. An allosteric redox switch in domain V of β
Kumar S; Chinnaraj M; Planer W; Zuo X; Macor P; Tedesco F; Pozzi N
J Biol Chem; 2021 Aug; 297(2):100890. PubMed ID: 34197876
[TBL] [Abstract][Full Text] [Related]
5. Identification of the binding site for fondaparinux on Beta2-glycoprotein I.
Kolyada A; De Biasio A; Beglova N
Biochim Biophys Acta; 2013 Oct; 1834(10):2080-8. PubMed ID: 23811002
[TBL] [Abstract][Full Text] [Related]
6. {beta}2 Glycoprotein I ({beta}2GPI) binds platelet factor 4 (PF4): implications for the pathogenesis of antiphospholipid syndrome.
Sikara MP; Routsias JG; Samiotaki M; Panayotou G; Moutsopoulos HM; Vlachoyiannopoulos PG
Blood; 2010 Jan; 115(3):713-23. PubMed ID: 19805618
[TBL] [Abstract][Full Text] [Related]
7. A peptide that mimics the Vth region of beta-2-glycoprotein I reverses antiphospholipid-mediated thrombosis in mice.
Ostertag MV; Liu X; Henderson V; Pierangeli SS
Lupus; 2006; 15(6):358-65. PubMed ID: 16830882
[TBL] [Abstract][Full Text] [Related]
8. Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I.
Artenjak A; Locatelli I; Brelih H; Simonič DM; Ulcova-Gallova Z; Swadzba J; Musial J; Iwaniec T; Stojanovich L; Conti F; Valesini G; Avčin T; Cohen Tervaert JW; Shoenfeld Y; Blank M; Ambrožič A; Sodin-Semrl S; Božič B; Čučnik S
Immunol Res; 2015 Feb; 61(1-2):35-44. PubMed ID: 25395339
[TBL] [Abstract][Full Text] [Related]
9. Libman-Sacks endocarditis associated with antiphospholipid syndrome and infection.
Blank M; Shani A; Goldberg I; Kopolovic J; Amigo MC; Magrini L; Shoenfeld Y
Thromb Res; 2004; 114(5-6):589-92. PubMed ID: 15507295
[TBL] [Abstract][Full Text] [Related]
10. Interaction of beta2-glycoprotein I with members of the low density lipoprotein receptor family.
Pennings MT; van Lummel M; Derksen RH; Urbanus RT; Romijn RA; Lenting PJ; de Groot PG
J Thromb Haemost; 2006 Aug; 4(8):1680-90. PubMed ID: 16879209
[TBL] [Abstract][Full Text] [Related]
11. An A1-A1 mutant with improved binding and inhibition of β2GPI/antibody complexes in antiphospholipid syndrome.
Kolyada A; Karageorgos I; Mahlawat P; Beglova N
FEBS J; 2015 Mar; 282(5):864-73. PubMed ID: 25546421
[TBL] [Abstract][Full Text] [Related]
12. Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome.
Blank M; Krause I; Fridkin M; Keller N; Kopolovic J; Goldberg I; Tobar A; Shoenfeld Y
J Clin Invest; 2002 Mar; 109(6):797-804. PubMed ID: 11901188
[TBL] [Abstract][Full Text] [Related]
13. Glycopeptide profiling of beta-2-glycoprotein I by mass spectrometry reveals attenuated sialylation in patients with antiphospholipid syndrome.
Kondo A; Miyamoto T; Yonekawa O; Giessing AM; Østerlund EC; Jensen ON
J Proteomics; 2009 Nov; 73(1):123-33. PubMed ID: 19706343
[TBL] [Abstract][Full Text] [Related]
14. Overlapping humoral autoimmunity links rheumatic fever and the antiphospholipid syndrome.
Blank M; Krause I; Magrini L; Spina G; Kalil J; Jacobsen S; Thiesen HJ; Cunningham MW; Guilherme L; Shoenfeld Y
Rheumatology (Oxford); 2006 Jul; 45(7):833-41. PubMed ID: 16705050
[TBL] [Abstract][Full Text] [Related]
15. Specific domain V reduction of beta-2-glycoprotein I induces protein flexibility and alters pathogenic antibody binding.
Buchholz I; McDonnell T; Nestler P; Tharad S; Kulke M; Radziszewska A; Ripoll VM; Schmidt F; Hammer E; Toca-Herrera JL; Rahman A; Delcea M
Sci Rep; 2021 Feb; 11(1):4542. PubMed ID: 33633190
[TBL] [Abstract][Full Text] [Related]
16. The orientation of beta2GPI on the plate is important for the binding of anti-beta2GPI autoantibodies by ELISA.
Iverson GM; Matsuura E; Victoria EJ; Cockerill KA; Linnik MD
J Autoimmun; 2002 Jun; 18(4):289-97. PubMed ID: 12144810
[TBL] [Abstract][Full Text] [Related]
17. β2-Glycoprotein I-Reactive T Cells in Autoimmune Disease.
Rauch J; Salem D; Subang R; Kuwana M; Levine JS
Front Immunol; 2018; 9():2836. PubMed ID: 30619248
[TBL] [Abstract][Full Text] [Related]
18. Correlation between beta2-glycoprotein I valine/leucine247 polymorphism and anti-beta2-glycoprotein I antibodies in patients with primary antiphospholipid syndrome.
Atsumi T; Tsutsumi A; Amengual O; Khamashta MA; Hughes GR; Miyoshi Y; Ichikawa K; Koike T
Rheumatology (Oxford); 1999 Aug; 38(8):721-3. PubMed ID: 10501418
[TBL] [Abstract][Full Text] [Related]
19. Biosensor analysis of beta2-glycoprotein I-reactive autoantibodies: evidence for isotype-specific binding and differentiation of pathogenic from infection-induced antibodies.
Metzger J; von Landenberg P; Kehrel M; Buhl A; Lackner KJ; Luppa PB
Clin Chem; 2007 Jun; 53(6):1137-43. PubMed ID: 17434906
[TBL] [Abstract][Full Text] [Related]
20. Antiphospholipid syndrome: 30 years and our contribution.
Koike T
Int J Rheum Dis; 2015 Feb; 18(2):233-41. PubMed ID: 25524556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
